Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors

Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors

US Patent 10675284 · Granted Jun 9, 2020

Estimated economic value: $88,835,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Indazole kinase inhibitor and use thereof2024
Sparse optimization method based on cross-shaped three-dimensional imaging sonar2024
Vibe-based three-dimensional sonar point cloud image segmentation method2022
Embedded processor-based three-dimensional acoustic imaging real-time signal pro2022
Point cloud mean background subtraction based method for 3D sonar image modeling2022
Fine granularity real-time supervision system based on edge computing2021
Distance statistics based method for 3D sonar point cloud image enhancement2021
Anti-PHG-tau antibodies and their uses2019
Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors2018
Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors2018
Anti-PHF-tau antibodies and their uses2018
Anti-PHF-tau antibodies and their uses2017